![](/img/cover-not-exists.png)
Cost-Effectiveness and Cost-Utility Analysis of Ingenol Mebutate Versus Diclofenac 3% and Imiquimod 5% in the Treatment of Actinic Keratosis in Spain
Elías, I., Ortega-Joaquín, N., de la Cueva, P., del Pozo, L.J., Moreno-Ramírez, D., Boada, A., Aguilar, M., Mirada, A., Mosquera, E., Gibbons, C., Oyagüez, I.Volume:
107
Journal:
Actas Dermo-Sifiliográficas (English Edition)
DOI:
10.1016/j.adengl.2016.05.022
Date:
July, 2016
File:
PDF, 834 KB
2016